ArticlePloS one2020

CTDSP1 inhibitor rabeprazole regulates DNA-PKcs dependent topoisomerase I degradation and irinotecan drug resistance in colorectal cancer.

Hiroya Matsuoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.